Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity

Rianne de Vries (Amersfoort, Netherlands), R. De Vries, P. Brinkman, S.K. Bootsma, E. Dijkers, F.H.C. De Jongh, P.J. Sterk

Source: International Congress 2015 – Developments in lung cancer diagnosis
Session: Developments in lung cancer diagnosis
Session type: Poster Discussion
Number: 3000
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rianne de Vries (Amersfoort, Netherlands), R. De Vries, P. Brinkman, S.K. Bootsma, E. Dijkers, F.H.C. De Jongh, P.J. Sterk. Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity. Eur Respir J 2015; 46: Suppl. 59, 3000

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


The utility of vibration response imaging for calculation of ppoFEV1 and ppoDL,CO in patients with lung cancer referred for resection – The influence of coexisting COPD
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013



COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Lung volume reduction effect after lobectomy in COPD patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013


Smoking status affects VRI assissted prediction of postoperative FEV1 and DL,CO in patients with lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014


Association between sputum cytology and lung function in patients with asthma and COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015


Lung cancer in COPD patients on home oxygen-therapy
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

LATE-BREAKING ABSTRACT: New algorithm of lung cancer diagnosis by analysis of exhaled breath with electronic nose and multifactorial logistic regression method
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014


Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015